[Potomania as a side-effect of topiramate].
Alda
Marta
M
García Campayo
Javier
J
Cerdán
Cristina
C
Laguna
Cristina
C
D000293:Adolescent; D000374:Aggression; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects*; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000188:drug therapy; D004327:Drinking Behavior / Q000187:drug effects*; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006955:Hypernatremia / Q000139:chemically induced* / Q000503:physiopathology / Q000523:psychology; D008297:Male; D026941:Sodium Channel Blockers / Q000009:adverse effects*; D000077236:Topiramate
D002257:Carbonic Anhydrase Inhibitors; D026941:Sodium Channel Blockers; D000077236:Topiramate; D005632:Fructose